Adalimumab and Infliximab ( DrugBank: Adalimumab, Infliximab )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
96クローン病2

96. クローン病


臨床試験数 : 2,442 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02332356
(ClinicalTrials.gov)
September 20144/1/2015Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's DiseaseTherapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's DiseaseCrohn DiseaseDrug: azathioprine or adalimumab and infliximabTokyo Medical and Dental UniversityNULLRecruiting16 Years65 YearsAll100Phase 3Japan
2NCT01338740
(ClinicalTrials.gov)
April 201118/4/2011Switching From Adalimumab to InfliximabProspective Study to Assess the Efficacy of Switching to Infliximab in Moderately to Severely Active Chrohn's Disease Patients With Primary Non-response or Loss of Response to AdalimumabCrohn's DiseaseDrug: Adalimumab and InfliximabUniversity Hospital, GhentAbbottCompleted18 Years75 YearsAll21Belgium